This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Dec;104(11):1497-501.

doi: 10.1172/JCI8849.

Anticancer drug targets: approaching angiogenesis

E Keshet¹, S A Ben-Sasson

Affiliations

PMID: 10587512
PMCID: PMC409872
DOI: 10.1172/JCI8849

Review

Anticancer drug targets: approaching angiogenesis

E Keshet et al. J Clin Invest. 1999 Dec.

. 1999 Dec;104(11):1497-501.

doi: 10.1172/JCI8849.

Authors

E Keshet¹, S A Ben-Sasson

Affiliation

¹ Department of Molecular Biology, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel. keshet@cc.huji.ac.il

PMID: 10587512
PMCID: PMC409872
DOI: 10.1172/JCI8849

No abstract available

PubMed Disclaimer

Similar articles

Angiogenesis and antiangiogenic therapy.
Sledge GW Jr, Miller KD. Sledge GW Jr, et al. Curr Probl Cancer. 2002 Jan-Feb;26(1):1-60. Curr Probl Cancer. 2002. PMID: 11961506 Review. No abstract available.
[Antiangiogenic therapy].
Toi M. Toi M. Gan To Kagaku Ryoho. 1998 Nov;25(13):2003-9. Gan To Kagaku Ryoho. 1998. PMID: 9838900 Review. Japanese.
[Research on the endothelium and new therapeutic strategies in tumors and cardiovascular diseases].
Dejana E. Dejana E. Recenti Prog Med. 1999 Feb;90(2):64-8. Recenti Prog Med. 1999. PMID: 10208094 Italian. No abstract available.
Evidence of efficacy: researchers investigating markers for angiogenesis inhibitors.
Brower V. Brower V. J Natl Cancer Inst. 2003 Oct 1;95(19):1425-7. doi: 10.1093/jnci/95.19.1425. J Natl Cancer Inst. 2003. PMID: 14519742 No abstract available.
Endothelial survival factors as targets for antineoplastic therapy.
Reinmuth N, Stoeltzing O, Liu W, Ahmad SA, Jung YD, Fan F, Parikh A, Ellis LM. Reinmuth N, et al. Cancer J. 2001 Nov-Dec;7 Suppl 3:S109-19. Cancer J. 2001. PMID: 11779081 Review.

See all similar articles

Cited by

Antiangiogenesis, loss of cell adhesion and apoptosis are involved in the antitumoral activity of Proteases from V. cundinamarcensis (C. candamarcensis) in murine melanoma B16F1.
Dittz D, Figueiredo C, Lemos FO, Viana CT, Andrade SP, Souza-Fagundes EM, Fujiwara RT, Salas CE, Lopes MT. Dittz D, et al. Int J Mol Sci. 2015 Mar 27;16(4):7027-44. doi: 10.3390/ijms16047027. Int J Mol Sci. 2015. PMID: 25826531 Free PMC article.
IL-1 is required for tumor invasiveness and angiogenesis.
Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. Voronov E, et al. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2645-50. doi: 10.1073/pnas.0437939100. Epub 2003 Feb 21. Proc Natl Acad Sci U S A. 2003. PMID: 12598651 Free PMC article.
Production and characterization of a humanized single-chain antibody against human integrin alphav beta3 protein.
Liu D, Wang C, Li C, Zhang X, Zhang B, Mi Z, An X, Tong Y. Liu D, et al. J Biol Chem. 2011 Jul 8;286(27):24500-7. doi: 10.1074/jbc.M110.211847. Epub 2011 May 23. J Biol Chem. 2011. PMID: 21606501 Free PMC article.
A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumors.
Wang F, Molina J, Satele D, Yin J, Lim VS, Adjei AA. Wang F, et al. Invest New Drugs. 2019 Aug;37(4):658-665. doi: 10.1007/s10637-018-0690-x. Epub 2018 Oct 31. Invest New Drugs. 2019. PMID: 30382439 Clinical Trial.
Combined interventional therapies of hepatocellular carcinoma.
Qian J, Feng GS, Vogl T. Qian J, et al. World J Gastroenterol. 2003 Sep;9(9):1885-91. doi: 10.3748/wjg.v9.i9.1885. World J Gastroenterol. 2003. PMID: 12970869 Free PMC article. Review.

See all "Cited by" articles

References

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182–1186. - PubMed
1. Rak J, Filmus J, Kerbel RS. Reciprocal paracrine interactions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesis. Eur J Cancer. 1996;32A:2438–2450. - PubMed
1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364. - PubMed
1. Ohh M, et al. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. J Clin Invest. 1999;104:1583–1591. - PMC - PubMed
1. Perez-Atayde AR, et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1997;150:815–821. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database